Science and Research

SPACE / AIO-TRK-0119: Single-Arm Phase II-Study in Patients with extensive stage small-cell lung cancer (ES-SCLC) with Poor Performance Status receiving Atezolizumab-Carboplatin-Etoposide.

Single-Arm Phase II-Study in Patients with extensive stage small-cell lung cancer (ES-SCLC) with Poor Performance Status receiving Atezolizumab-Carboplatin-Etoposide

Study details
Study-ID: NCT04221529, 2019-001707-21
Study-ID: NCT04221529, 2019-001707-21
DZL Disease Area: LC
DZL Disease Area: LC
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center, DZL on steering board
DZL Role: DZL recruiting center, DZL on steering board
Funding: Externally - industry, Externally - public
Funding: Externally - industry, Externally - public
DZL Participating Sites: ARCN, CPC-M
DZL Participating Sites: ARCN, CPC-M
Start Date: 06.01.2020
Completion Date: 11.04.2025
Status: Closed
Status: Closed
DZL recruiting center, DZL on steering board
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.